These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 4733318)

  • 61. [Oxidation of xenobiotics during chemical carcinogenesis and experimental neoplastic growth].
    Poliakov VM; Lankin VZ; Gurevich SM
    Dokl Akad Nauk SSSR; 1976 Jan; 226(2):471-3. PubMed ID: 1248367
    [No Abstract]   [Full Text] [Related]  

  • 62. Effects of non-gonadal hormones on rat liver drug-metabolizing enzymes and cytochrome P-450 during early postnatal development [proceedings].
    Leakey JE; Fouts JR; Dutton GJ
    Biochem Soc Trans; 1979 Oct; 7(5):1103-4. PubMed ID: 510715
    [No Abstract]   [Full Text] [Related]  

  • 63. Hepatic mixed-function oxidase of the mallard duck (Anas platyrhynchos).
    Shackelford ME; Khan MA
    Comp Biochem Physiol C Comp Pharmacol; 1981; 70(1):77-84. PubMed ID: 6117412
    [No Abstract]   [Full Text] [Related]  

  • 64. Sex-dependent effects of cyclic AMP on the hepatic mixed function oxidase system.
    Ross WE; Simrell C; Oppelt WW
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):319-32. PubMed ID: 4349298
    [No Abstract]   [Full Text] [Related]  

  • 65. Effects of vitamin A deficiency on hepatic and extrahepatic mixed-function oxidase and epoxide-metabolizing enzymes in guinea pig and rabbit.
    Miranda CL; Mukhtar H; Bend JR; Chhabra RS
    Biochem Pharmacol; 1979 Sep; 28(18):2713-6. PubMed ID: 497022
    [No Abstract]   [Full Text] [Related]  

  • 66. Nicotinamide administration alters the activities of hepatic microsomal mixed function oxidases.
    Batra JK; Raj HG; Venkitasubramanian TA
    Experientia; 1980 Nov; 36(11):1311. PubMed ID: 6450052
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of "drugs for liver disease" on hepatotoxic action of carbon tetrachloride. II. Effect of protoporphyrin and phosphorylcholine on microsomal drug-metabolizing enzyme activities and the components in injuried liver.
    Ogiso T; Kobayashi T; Kuhara K; Kato Y
    Jpn J Pharmacol; 1975 Aug; 25(4):411-21. PubMed ID: 813044
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of ethoxyquin on the carbon tetrachloride-induced changes in rat hepatic microsomal enzymes.
    Cawthorne MA; Palmer ED; Green J
    Biochem Pharmacol; 1973 Aug; 22(16):2066-8. PubMed ID: 4353671
    [No Abstract]   [Full Text] [Related]  

  • 69. Decrease of the activity of the mixed function oxidase system in regenerating rat liver: an alternative explanation.
    Presta M; Aletti MG; Ragnotti G
    Biochem Biophys Res Commun; 1980 Jul; 95(2):829-34. PubMed ID: 7417291
    [No Abstract]   [Full Text] [Related]  

  • 70. Interaction of volatile anesthetics with rat hepatic microsomal cytochrome P-450.
    Takahashi S; Shigematsu A; Furukawa T
    Anesthesiology; 1974 Oct; 41(4):375-9. PubMed ID: 4413930
    [No Abstract]   [Full Text] [Related]  

  • 71. Effects of N-nitrosodiethylamine on murine hepatic mixed-function-oxidase activities.
    Tucker AN; Tang T; Friedman MA
    J Environ Pathol Toxicol; 1978; 2(2):571-8. PubMed ID: 368284
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Seasonal change and sex difference in drug-metabolizing activity in frog liver microsomes.
    Miura Y; Hisaki H; Nagai T; Nagai T
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 85(2):353-5. PubMed ID: 2879695
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of pyrrolizidine alkaloids from tansy ragwort (senecio jacobaea) on hepatic drug-metabolizing enzymes in male rats.
    Miranda CL; Cheeke PR; Buhler DR
    Biochem Pharmacol; 1980 Oct; 29(19):2645-9. PubMed ID: 7426068
    [No Abstract]   [Full Text] [Related]  

  • 74. Changes in rat hepatic microsomal mixed function oxidase activity following exposure to halothane under various oxygen concentrations.
    Knights KM; Gourlay GK; Cousins MJ
    Biochem Pharmacol; 1987 Mar; 36(6):897-906. PubMed ID: 3105540
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of spironolactone on hepatic microsomal monooxygenase and azoreductase activities.
    Fujita S; Uesugi T; Ohta M; Kitani K
    Res Commun Chem Pathol Pharmacol; 1982 Apr; 36(1):87-103. PubMed ID: 7079590
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Induction of liver microsomal mixed-function oxidases by volatile hydrocarbons.
    Cinti DL; Lemelin MA; Christian J
    Biochem Pharmacol; 1976 Jan; 25(1):100-3. PubMed ID: 814904
    [No Abstract]   [Full Text] [Related]  

  • 77. Ascorbic acid and drug metabolism.
    Zannoni VG; Flynn EJ; Lynch M
    Biochem Pharmacol; 1972 May; 21(10):1377-92. PubMed ID: 4402218
    [No Abstract]   [Full Text] [Related]  

  • 78. Effect of aroclor 1016 and 1242 on enzyme systems in the rat.
    Iverson F; Villeneuve DC; Grant DL; Hatina GV
    Bull Environ Contam Toxicol; 1975 Apr; 13(4):456-63. PubMed ID: 805614
    [No Abstract]   [Full Text] [Related]  

  • 79. [Biopharmaceutical studies on neuroleptic butyrophenones. V. Effects of chronic treatment on adrenal and hepatic drug-metabolizing enzyme system in rats (author's transl)].
    Aimoto T; Unno K; Hayashi H; Murata T
    Yakugaku Zasshi; 1979 Oct; 99(10):1014-20. PubMed ID: 544743
    [No Abstract]   [Full Text] [Related]  

  • 80. Effect of alpha-pinene on the mixed function microsomal oxidase system in the rat.
    Pap A; Szarvas F
    Acta Med Acad Sci Hung; 1976; 33(4):379-85. PubMed ID: 1032243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.